Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,300,074

« Back to Dashboard

Title: Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
Abstract:This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
Inventor(s): Gold; Larry (Boulder, CO), Eaton; Bruce (Boulder, CO), Smith; Drew (Boulder, CO), Wecker; Matthew (Boulder, CO), Jensen; Kirk (Boulder, CO)
Assignee: Gilead Sciences, Inc. (Foster, CA)
Filing Date:Oct 04, 1999
Application Number:09/412,017
Claims:1. A covalent complex between a nucleic acid ligand and a target molecule, wherein said nucleic acid ligand comprises a chemically reactive functional unit, comprising:

a) preparing a candidate mixture of nucleic acids comprising at least one functional unit;

b) contacting said candidate mixture with said target molecule, wherein nucleic acid sequences which bind covalently with said target molecule form nucleic acid-target molecule complexes;

c) partitioning the nucleic acid-target molecule complexes from the remainder of the candidate mixture, whereby a covalent complex may be identified.

2. The covalent complex of claim 1 wherein said nucleic acid ligand is selected from the sequences listed in Tables II and IV.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.